{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:15:10Z","timestamp":1789143310136,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00431-020-03872-5","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T21:02:43Z","timestamp":1605301363000},"page":"585-590","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Recurrence rate of infantile hemangioma after oral propranolol therapy"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8953-7175","authenticated-orcid":false,"given":"Giovanni","family":"Frongia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Oun","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianeb","family":"Mehrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"2","key":"3872_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","volume":"25","author":"C Kilcline","year":"2008","unstructured":"Kilcline C, Frieden IJ (2008) Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 25(2):168\u2013173","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"3872_CR2","doi-asserted-by":"publisher","first-page":"F85","DOI":"10.1136\/archdischild-2014-306197","volume":"100","author":"R Goelz","year":"2015","unstructured":"Goelz R, Poets CF (2015) Incidence and treatment of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed 100(1):F85\u2013F91","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"3872_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00403-016-1635-x","volume":"308","author":"S De Jong","year":"2016","unstructured":"De Jong S, Itinteang T, Withers AHJ, Davis PF, Tan ST (2016) Does hypoxia play a role in infantile hemangioma? Arch Dermatol Res 308:219\u2013227","journal-title":"Arch Dermatol Res"},{"key":"3872_CR4","doi-asserted-by":"crossref","unstructured":"Smith CJF, Friedlander SF, Guma M, Kavanaugh A, Chambers CD (2017) Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res 109(11):809\u2013815","DOI":"10.1002\/bdr2.1023"},{"issue":"4","key":"3872_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1067\/mjd.2003.200","volume":"48","author":"AL Bruckner","year":"2003","unstructured":"Bruckner AL, Frieden IJ (2003) Hemangiomas of infancy. J Am Acad Dermatol 48(4):477\u2013493","journal-title":"J Am Acad Dermatol"},{"key":"3872_CR6","doi-asserted-by":"crossref","unstructured":"Chang L, Haggstrom A, Drolet B, Baselga B, Chamlin S, Garzon M et al (2008) Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122(2):360\u2013367","DOI":"10.1542\/peds.2007-2767"},{"key":"3872_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1525-1470.1997.tb00232.x","volume":"14","author":"O Enjolras","year":"1997","unstructured":"Enjolras O, Gelbert F (1997) Superficial hemangiomas: associations and management. Pediatr Dermatol 14:173\u2013179","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"3872_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1468-3083.2011.04105.x","volume":"25","author":"C Leaute-Labreze","year":"2011","unstructured":"Leaute-Labreze C, Prey S, Ezzedine K (2011) Infantile haemangioma: part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 25(11):1254\u20131260","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"3872_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/archderm.140.8.963","volume":"140","author":"ME George","year":"2004","unstructured":"George ME, Sharma V, Jacobson J, Simon S, Nopper AJ (2004) Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 140(8):963\u2013969","journal-title":"Arch Dermatol"},{"issue":"1","key":"3872_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-019-03504-7","volume":"179","author":"N Zavras","year":"2020","unstructured":"Zavras N, Dimopoulou A, Machairas N, Paspala A, Vaos G (2020) Infantile hepatic hemangioma: current state of the art, controversies, and perspectives. Eur J Pediatr 179(1):1\u20138","journal-title":"Eur J Pediatr"},{"issue":"1","key":"3872_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00431-018-3290-z","volume":"178","author":"JC L\u00f3pez-Guti\u00e9rrez","year":"2019","unstructured":"L\u00f3pez-Guti\u00e9rrez JC (2019) Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. Eur J Pediatr 178(1):1\u20136","journal-title":"Eur J Pediatr"},{"issue":"24","key":"3872_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Ta\u00efeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358(24):2649\u20132651","journal-title":"N Engl J Med"},{"issue":"12","key":"3872_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","volume":"147","author":"CJ Price","year":"2011","unstructured":"Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, Connelly EA (2011) Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 147(12):1371\u20131376","journal-title":"Arch Dermatol"},{"issue":"6","key":"3872_CR14","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/bjd.12432","volume":"169","author":"CK Ahogo","year":"2013","unstructured":"Ahogo CK, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Ta\u00efeb A, L\u00e9aut\u00e9-Labr\u00e8ze C (2013) Factors associated with the relapse of infantile haemangiomas in children treated with oral propranolol. Br J Dermatol 169(6):1252\u20131256","journal-title":"Br J Dermatol"},{"issue":"6","key":"3872_CR15","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1525-1470.2011.01644.x","volume":"28","author":"L Bagazgoitia","year":"2011","unstructured":"Bagazgoitia L, Hernandez-Martin A, Torrelo A (2011) Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 28(6):658\u2013662","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"3872_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/pde.12239","volume":"31","author":"A Giachetti","year":"2014","unstructured":"Giachetti A, Garcia-Monaco R, Sojo M, Scacchi MF, Cernadas C, Guerchicoff Lemcke M, Dovasio F (2014) Long-term treatment with oral propranolol reduces relapses of infantile hemangiomas. Pediatr Dermatol 31(1):14\u201320","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"3872_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/bjd.12417","volume":"169","author":"S Causs\u00e9","year":"2013","unstructured":"Causs\u00e9 S, Aubert H, Saint-Jean M, Puzenat E, Bursztejn AC, Eschard C, Mah\u00e9 E, Maruani A, Mazereeuw-Hautier J, Dreyfus I, Miquel J, Chiaverini C, Boccara O, Hadj-Rabia S, Stalder JF, Barbarot S, the Groupe de Recherche Clinique en Dermatologie P\u00e9diatrique (2013) Propranolol-resistant infantile haemangiomas. Br J Dermatol 169(1):125\u2013129","journal-title":"Br J Dermatol"},{"issue":"1","key":"3872_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","volume":"131","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L, MacLellan-Tobert S, Mancini AJ, Metry D, Puttgen KB, Seefeldt M, Sidbury R, Ward KM, Blei F, Baselga E, Cassidy L, Darrow DH, Joachim S, Kwon EKM, Martin K, Perkins J, Siegel DH, Boucek RJ, Frieden IJ (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131(1):128\u2013140","journal-title":"Pediatrics"},{"issue":"10","key":"3872_CR19","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1111\/j.1651-2227.2012.02783.x","volume":"101","author":"A Georgountzou","year":"2012","unstructured":"Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T (2012) Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatr 101(10):e469\u2013e474","journal-title":"Acta Paediatr"},{"issue":"6","key":"3872_CR20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/pde.12229","volume":"30","author":"A Georgountzou","year":"2013","unstructured":"Georgountzou A, Karavitakis E, Klimentopoulou A, Xaidara A, Kakourou T (2013) Dramatic shift in the infantile hemangioma treatment paradigm at a single institution. Pediatr Dermatol 30(6):751\u2013752","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"3872_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/bjd.12189","volume":"168","author":"DJ Hermans","year":"2013","unstructured":"Hermans DJ, Bauland CG, Zweegers J, van Beynum IM, van der Vleuten CJ (2013) Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions. Br J Dermatol 168(4):837\u2013843","journal-title":"Br J Dermatol"},{"issue":"8","key":"3872_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","volume":"372","author":"C L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","unstructured":"L\u00e9aut\u00e9-Labr\u00e8ze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, Phillips RJ, Caceres H, Lopez Gutierrez JC, Ballona R, Friedlander SF, Powell J, Perek D, Metz B, Barbarot S, Maruani A, Szalai ZZ, Krol A, Boccara O, Foelster-Holst R, Bosch MI, Su J, Buckova H, Torrelo A, Cambazard F, Grantzow R, Wargon O, Wyrzykowski D, Roessler J, Bernabeu-Wittel J, Valencia AM, Przewratil P, Glick S, Pope E, Birchall N, Benjamin L, Mancini AJ, Vabres P, Souteyrand P, Frieden IJ, Berul CI, Mehta CR, Prey S, Boralevi F, Morgan CC, Heritier S, Delarue A, Voisard JJ (2015) A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 372(8):735\u2013746","journal-title":"N Engl J Med"},{"issue":"1","key":"3872_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/SCS.0000000000002206","volume":"27","author":"ZM MacIsaac","year":"2016","unstructured":"MacIsaac ZM, Nayar HS, Gehris R, Mehta D, Geisler S, Grunwaldt LJ et al (2016) Treatment for infantile hemangiomas: selection criteria, safety, and outcomes using oral propranolol during the early phase of propranolol use for hemangiomas. J Craniofac Surg 27(1):159\u2013162","journal-title":"J Craniofac Surg"},{"issue":"10","key":"3872_CR24","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1440-1754.2012.02521.x","volume":"48","author":"RJ Phillips","year":"2012","unstructured":"Phillips RJ, Penington AJ, Bekhor PS, Crock CM (2012) Use of propranolol for treatment of infantile haemangiomas in an outpatient setting. J Paediatr Child Health 48(10):902\u2013906","journal-title":"J Paediatr Child Health"},{"issue":"12","key":"3872_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/archdischild-2014-306514","volume":"99","author":"L Solman","year":"2014","unstructured":"Solman L, Murabit A, Gnarra M, Harper JI, Syed SB, Glover M (2014) Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol. Arch Dis Child 99(12):1132\u20131136","journal-title":"Arch Dis Child"},{"issue":"1","key":"3872_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bcp.12235","volume":"78","author":"Y Lou","year":"2014","unstructured":"Lou Y, Peng WJ, Cao Y, Cao DS, Xie J, Li HH (2014) The effectiveness of propranolol in treating infantile haemangiomas: a meta-analysis including 35 studies. Br J Clin Pharmacol 78(1):44\u201357","journal-title":"Br J Clin Pharmacol"},{"issue":"e","key":"3872_CR27","doi-asserted-by":"publisher","first-page":"20151754","DOI":"10.1542\/peds.2015-1754","volume":"137","author":"SD Shah","year":"2016","unstructured":"Shah SD, Baselga E, Mccuaig C, Pope E, Coulie J (2016) Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics 137(e):20151754","journal-title":"Pediatrics"},{"issue":"4","key":"3872_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ijporl.2010.01.001","volume":"74","author":"AP Zimmermann","year":"2010","unstructured":"Zimmermann AP, Wiegand S, Werner JA, Eivazi B (2010) Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 74(4):338\u2013342","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"3872_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/pde.12089","volume":"30","author":"AL Marqueling","year":"2013","unstructured":"Marqueling AL, Oza V, Frieden IJ, Puttgen KB (2013) Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol 30(2):182\u2013191","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"3872_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0022-3468(83)80043-8","volume":"18","author":"MC Finn","year":"1983","unstructured":"Finn MC, Glowacki J, Mulliken JB (1983) Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 18(6):894\u2013900","journal-title":"J Pediatr Surg"},{"key":"3872_CR31","doi-asserted-by":"crossref","unstructured":"Shah SD, Baselga E, McCuaig C, Pope E, Coulie J, Boon LM, Garzon MC, Haggstrom AN, Adams D, Drolet BA, Newell BD, Powell J, Garc\u00eda-Romero MT, Chute C, Roe E, Siegel DH, Grimes B, Frieden IJ (2016) Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics 137(4):e20151754","DOI":"10.1542\/peds.2015-1754"},{"key":"3872_CR32","doi-asserted-by":"crossref","unstructured":"Chang SJ, Yu W, Gu Y, Han Y, Shang Y, Chang L, Jin Y, Ma G, Qiu Y, Lin X (2019) Location of infantile hemangioma is a predictor of volumetric sequelae after involution. J Dermatol 46(5):371\u2013375","DOI":"10.1111\/1346-8138.14847"},{"key":"3872_CR33","doi-asserted-by":"crossref","unstructured":"Baselga E, Roe E, Coulie J, Mu\u00f1oz FZ, Boon LM, McCuaig C, Hernandez-Mart\u00edn A, Gich I, Puig L (2016) Risk factors for degree and type of sequelae after involution of untreated hemangiomas of infancy. JAMA Dermatol 152(11):1239\u20131243","DOI":"10.1001\/jamadermatol.2016.2905"},{"key":"3872_CR34","unstructured":"Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, Lucky AW, Mancini AJ, Metry DW, Nopper AJ, Frieden IJ (2008) Hemangioma investigator group. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 122(2):360\u2013367"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-020-03872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-020-03872-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-020-03872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T07:10:06Z","timestamp":1610953806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-020-03872-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3872"],"URL":"https:\/\/doi.org\/10.1007\/s00431-020-03872-5","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"8 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The local ethics committee approved this study.Ethical approval was obtained from the institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not necessary, in accordance with institutional ethic review board, due to retrospective study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"N\/A","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}